Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Psychemedics Corporation (PMD) vs XWELL, Inc. (XWEL)

Psychemedics Corporation and XWELL, Inc. are both Diagnostics & Research companies. Psychemedics Corporation is the larger, with a market value of $15.7M against $7.6M — 2.1× the size. XWELL, Inc. grew revenue faster over the last twelve months: −7.58% against −10.9%. Psychemedics Corporation has the higher net margin (−9.45% vs −117.8%) and the lower return on invested capital (−31.4% vs 0.00%). Across the 18 metrics below, Psychemedics Corporation leads on 10 and XWELL, Inc. on 8.

Valuation

Metric PMD XWEL Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.80 0.27 4.87
P/B 3.05 0.92 3.12
Price to free cash flow 19.46 n/m 34.02
EV/EBITDA 77.29 n/m 25.20
EV/Sales 0.74 0.30 5.66
Earnings yield (11.99%) (597.75%) (1.75%)
Free cash flow yield 5.14% (178.41%) (0.13%)

Profitability

Metric PMD XWEL Diagnostics & Research median
Gross margin 36.07% 34.34% 50.89%
Operating margin (9.62%) (61.31%) (8.57%)
Net margin (9.45%) (117.83%) (6.37%)
Free cash flow margin 4.02% (47.65%) 0.00%
Return on equity (31.54%) (557.21%) (2.92%)
Return on assets (18.03%) (155.10%) (6.71%)
Return on invested capital (31.42%) 0.00% 0.00%

Growth

Metric PMD XWEL Diagnostics & Research median
Revenue growth (TTM) (10.92%) (7.58%) 7.69%
EPS growth (last fiscal year) 55.56% (38.80%) —
Revenue growth, 5-year CAGR (12.18%) 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMD XWEL Diagnostics & Research median
Debt to equity 0.01 0.00 0.11
Current ratio 1.82 2.27 2.02
Net debt to EBITDA (7.26) (0.08) 0.78

Dividend

Metric PMD XWEL Diagnostics & Research median
Dividend yield 4.79% — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric PMD XWEL Diagnostics & Research median
Market cap 15.70m 7.64m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack